VolitionRx Limited Interest Expense Nonoperating
VolitionRx Limited (VNRX) reported Interest Expense Nonoperating of $740.39 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- VolitionRx Limited interest expense nonoperating for the quarter ending 2026-06-30 was $740.39K, a 500.20% increase year-over-year.
- VolitionRx Limited interest expense nonoperating for the quarter ending 2026-03-31 was $125.84K, a 30.18% increase year-over-year.
- VolitionRx Limited interest expense nonoperating for the quarter ending 2025-06-30 was $123.36K.
- VolitionRx Limited interest expense nonoperating for the quarter ending 2025-03-31 was $96.67K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month |
|---|---|---|
| 2026-06-30 | $740.39K 10-Q · filed 2026-08-13 | $866.23K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $125.84K 10-Q · filed 2026-05-14 | |
| 2025-06-30 | $123.36K 10-Q · filed 2026-08-13 | $220.03K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $96.67K 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |